RxDoctor Payments Data

Lisa Beyers, APRN

Family · Oaktown, INNPI 1104538685

Payments from drug & device makers

$486in general payments, 2019–2025

Across 24 payments — averaging $20.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$107
  • Otsuka America Pharmaceutical, Inc.$93
  • AbbVie$48
  • Novo Nordisk$44
  • Pfizer$41
  • Teva Pharmaceuticals USA, Inc.$37
  • plus $115 from 7 others

What the payments were for

  • Food & beverage$486100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$486 in reported general payments places this provider in the 50th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$80,055
Medicare patients
252
Services billed
1,438

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone12$79

Paid to pharmacies, not to this prescriber.

Other family in Oaktown

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →